Polycronis Paul Akouris

Mr. Polycronis Paul Akouris

Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2023 in Nature Reviews Urology
Verified
Journal Article
Closed access
PDF file
JCJohn Antonio Chmiel
John Antonio Chmiel
GSGerrit A. Stuivenberg
Gerrit A. Stuivenberg
KAKait F. Al
Kait F. Al
Polycronis Paul AkourisPolycronis Paul Akouris
Polycronis Paul Akouris
HRHassan Razvi
Hassan Razvi
JBJennifer Bjazevic
Jennifer Bjazevic

21 December 2022 in mSphere
Verified
Journal Article
Open access
GSGerrit Alojzi Stuivenberg
Gerrit Alojzi Stuivenberg
JCJohn Antonio Chmiel
John Antonio Chmiel
Polycronis Paul AkourisPolycronis Paul Akouris
Polycronis Paul Akouris
JBJeremy Burton
Jeremy Burton
GRGregor Reid
Gregor Reid
Chronic kidney disease (CKD) affects approximately 10% of the global population and has limited treatment options. The accumulation of gut microbiota-derived uremic toxins, such as para -cresol ( p -cresol) and p- cresyl sulfate, is associated with the onset of comorbidities (i.e., atherosclerosis and cognitive disorders) in CKD.

8 May 2024 in Gut Microbes
Verified
Journal Article
Open access
Polycronis Paul AkourisPolycronis Paul Akouris
Polycronis Paul Akouris
GSGerrit Alojzi Stuivenberg
Gerrit Alojzi Stuivenberg
JCJohn Antonio Chmiel
John Antonio Chmiel
WKWongsakorn Kiattiburut
Wongsakorn Kiattiburut
APAnnabel Poon
Annabel Poon
JBJeremy Burton
Jeremy Burton
Ethanolamine is an abundant compound in the gastrointestinal tract and a valuable source of carbon and nitrogen for pathogenic bacteria harboring ethanolamine utilization (eut) genes. Eut-positive pathogens can consume free ethanolamine to outcompete commensal microbes, which often lack eut genes, and establish infection. Ethanolamine can also act as a host recognition signal for eut-positive pathogens to upregulate virulence genes during colonization. Therefore, reducing free ethanolamine titers may represent a novel approach to preventing infection by eut-positive pathogens. Interestingly, the commensal microorganism Levilactobacillus brevis ATCC 14869 was found to encode over 18 eut genes within its genome. This led us to hypothesize that L. brevis can compete with eut-positive pathogens by clearing free ethanolamine from the environment. Our results demonstrate that despite being unable to metabolize ethanolamine under most conditions, L. brevis ATCC 14869 responds to the compound by increasing the expression of genes encoding proteins involved in microcompartment formation and adhesion to the intestinal epithelial barrier. The improved intestinal adhesion of L. brevis in the presence of ethanolamine also enhanced the exclusion of eut-positive pathogens from adhering to intestinal epithelial cells. These findings support further studies to test whether L. brevis ATCC 14869 can counter enteric pathogens and prevent or reduce the severity of infections. Overall, the metabolic capabilities of L. brevis ATCC 14869 offer a unique opportunity to add to the armamentarium of antimicrobial therapies as well as our understanding of the mechanisms used by beneficial microbes to sense and adapt to host microenvironments.

Verified
Journal Article
Open access
PDF file
Scarlett Puebla-BarraganScarlett Puebla-Barragan
Scarlett Puebla-Barragan
Polycronis Paul AkourisPolycronis Paul Akouris
Polycronis Paul Akouris
KAKait Al
Kait Al
CCCharles Carr
Charles Carr
BLBritney Taylor Lamb
Britney Taylor Lamb
GRGregor Reid
Gregor Reid
Vaginal malodour is a sign of dysbiosis. The biogenic amines (BAs) cadaverine, putrescine and tyramine are known to be causative compounds. Recent reports suggest these compounds produced by pathogens might have a role beyond causing malodour; namely inhibiting the growth of lactobacilli bacteria that are crucial in the maintenance of vaginal homeostasis. The aim of this study was to identify whether certain lactobacilli strains could reduce BAs and to evaluate how Lactobacillus species were affected by these compounds. Using LC–MS and HPLC-UV, five Lactobacillus crispatus strains were identified as being capable of significantly reducing BAs from the media under in vitro conditions. Through 16S rRNA gene sequencing of vaginal swabs exposed to Bas, cadaverine was found to reduce the relative abundance of lactobacilli. When L. crispatus was exposed to media supplemented with BAs with an HCl adjusted lower pH, its growth was enhanced, demonstrating the relevance of the maintenance of an acidic vaginal environment. If strains are to be developed for probiotic application to alleviate bacterial vaginosis and other conditions affecting large numbers of women worldwide, their ability to adapt to Bas and regulate pH should be part of the experimentation.

2 December 2021 in Journal of Food Science and Technology
Verified
Journal Article
Open access
PDF file
GSGerrit Alojzi Stuivenberg
Gerrit Alojzi Stuivenberg
BDBrendan Daisley
Brendan Daisley
Polycronis Paul AkourisPolycronis Paul Akouris
Polycronis Paul Akouris
GRGregor Reid
Gregor Reid
Recent studies suggest histamine and d-lactate may negatively impact host health. As excess histamine is deleterious to the host, the identification of bacterial producers has contributed to concerns over the consumption of probiotics or live microorganisms in fermented food items. Some probiotic products have been suspected of inducing d-lactic-acidosis; an illness associated with neurocognitive symptoms such as ataxia. The goals of the present study were to test the in vitro production of histamine and d-lactate by a 24-strain daily synbiotic and to outline methods that others can use to test for their production. Using enzymatic based assays, no significant production of histamine was observed compared to controls (P > 0.05), while d-lactate production was comparable to a commercially available probiotic with no associated health risk. These assays provide a means to add to the safety profile of synbiotic and probiotic products.

18 April 2023 in Fermentation
Verified
Journal Article
Open access
PDF file
GSGerrit Alojzi Stuivenberg
Gerrit Alojzi Stuivenberg
JCJohn Antonio Chmiel
John Antonio Chmiel
Polycronis Paul AkourisPolycronis Paul Akouris
Polycronis Paul Akouris
JWJessica White
Jessica White
HWHannah Wilcox
Hannah Wilcox
GRGregor Reid
Gregor Reid
Chronic kidney disease (CKD) disproportionately affects populations in developing countries. In sub-Saharan Africa, CKD prevalence is high (12–23%) and is associated with cardiovascular manifestations. Uremic toxins, especially p-cresol and p-cresyl sulfate, are associated with the disease. Reducing uremic toxins in the body slows disease progression and improves patient outcomes. Probiotic Bifidobacterium breve HRVD521-US, B. animalis HRVD524-US, B. longum SD-BB536-JP, and B. longum SD-CECT7347-SP internalize p-cresol and improve longevity in vivo. In 2002, Tanzanian communities were taught to produce probiotic yogurt (Fiti®) supplemented with Lacticaseibacillus rhamnosus GR-1. This has expanded to over 100 community producers across the country. To produce yogurt that could reduce the burden of CKD by sequestering uremic toxins, we decided to test the addition of p-cresol-clearing bifidobacterial strains. By repeating the Fiti® production process performed in Tanzanian communities and adding a bifidobacterial strain, we found that they were successfully incorporated into the yogurt without any detrimental effect on sensory properties or viable counts. Three of the four strains significantly reduced p-cresol when added to a simulated colonic environment. In conclusion, this study has shown that Fiti® sachets provided to Tanzanian communities to produce yogurt can be supplemented with strains that can potentially confer additional health benefits.